Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06792292

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Cancer can develop in the colon, or large bowel. Examination of the colon with a tube fitted with a camera is called a colonoscopy.

Colonoscopy allows detection of small growths in the colon, called "polyps". Polyps can often be removed during colonoscopy. Some of these polyps are called adenomas and can become cancer after several years.

A good colonoscopy aims to find and take out as many of these polyps as possible.

A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out.

New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy.

The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

45 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital Delta Chirec

Auderghem, Brussels Capital, 1160, Belgium

Location contact

Erik Francois, M.D.

CONTACT

[email protected]

Erik Francois, M.D.

PRINCIPAL_INVESTIGATOR

Philippe Langlet, M.D.

PRINCIPAL_INVESTIGATOR

About this study

The colon is a part of the bowel where colon cancer can develop.

It is possible to prevent colon cancer by doing a screening test called a colonoscopy.

The colonoscopy procedure allows detection of "polyps" which can often be removed during the procedure. Some of these polyps are called adenomas and can become cancer after several years.

A good colonoscopy aims to find and take out as many of these polyps as possible.

A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out.

New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy.

The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.

Patients who are scheduled to have screening colonoscopy and who agree to participate, and are aged 45 years or more, will be randomly assigned to receive either standard colonoscopy or AI-assisted colonoscopy.

The main objective of this study is the difference in the ADR between a conventional colonoscopy procedure and an AI-assisted colonoscopy procedure.

Secondary objectives will compare the 2 groups (conventional colonoscopy and AI-assisted colonoscopy) regarding polyp size, polyp quantity, polyp histology (laboratory analysis of the polyp that was taken out), polyp dysplasia grade (how close the polyp is to cancer), polyp location in the colon, endoscopist experience (older or younger doctor), time of day and colonoscopy preparation quality (how clean the bowel is).

With these results we can show that AI-assisted colonoscopy is useful or not to help better prevent colon cancer.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient (woman or man) candidate for a screening colonoscopy - Age: 45 to 74 years included
  • Absence of inflammatory bowel disease
  • Absence of significant digestive symptoms indicating colonoscopy (i.e. screening is the only indication for the examination)
  • Patient able to understand the concept of the study and agreeing to participate

Exclusion criteria

  • Patient outside the inclusion age
  • All exclusion criteria for a colonoscopy.
  • The indication for colonoscopy is not simple screening; for example, assessment of anemia, rectal bleeding, weight loss or abdominal pain.
  • Patient's refusal to participate, or patient's inability to understand the study concept
  • Any patient with major psychological or psychiatric disorders.

Treatment and study plan

conventional colonoscopy procedure

Other

Study subjects in this interventional arm will undergo conventional colonoscopy.

artificial intelligence-assisted colonoscopy procedure

Other

Study subjects in this interventional arm will undergo colonoscopy done with a commercially-available module that uses artificial intelligence to highlight suspected polyps on the screen during colonoscopy. This module also attempts to characterize the detected polyp as adenomatous or not. The detection and characterization of polyps is in real time, during the procedure.

Primary outcomes

  1. Adenoma Detection Rate in Conventional versus Artificial Intelligence-Assisted Colonoscopy

    Time frame: 1 day

    The main objective of this study is the difference in the detection rate of colorectal adenomas in individuals over 45 years old during colonoscopies for colon cancer screening between a conventional colonoscopy procedure (CCP) and a colonoscopy procedure with AI (ACP).

Secondary outcomes

  1. The difference in the detection rate of colorectal adenomas according to size by group (5 mm/6-9 mm/>10 mm) between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

    Time frame: 1 day

    Detection rate of diminutive, small, and large polyps will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

  2. The difference in the detection rate of colorectal adenomas according to the number per group (n=1-2/n= 3-10/n >10) between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

    Time frame: 1 day

    The number of adenomas detected during the procedure will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

  3. The difference in the detection rate of colorectal adenomas based on histology by group (hyperplastic/conventional adenomas/serrated adenomas/adenocarcinoma) between a conventional colonoscopic procedure (PCC) and a colonoscopy procedure with AI.

    Time frame: 1 month

    Adenomas have different histologic types. After obtaining histology, the detection rate of the various histologic types will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

  4. The difference in detection rate of colorectal adenomas based on dysplastic grade by group

    Time frame: 1 day

    The difference in detection rate of colorectal adenomas based on dysplastic grade

    by group (conventional or serrated adenomas/low-grade dysplasia/high-grade dysplasia/adenocarcinoma) or Narrow Band Imaging International Colorectal Endoscopic (NICE) (stages 1, 2 or 3) classification or Japan Narrow Band Imaging Expert Team (JNET) classification (stages 1, 2A and 2B, or 3) between a conventional colonoscopy procedure (CCP) and a colonoscopy procedure with AI (ACP).

  5. The difference in the detection rate of colorectal adenomas depending on the location by group (rectum/left colon/transverse colon/right colon) between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

    Time frame: 1 day

    Location of adenomas will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

  6. The difference in the detection rate of colorectal adenomas according to experience by group of colonoscopists

    Time frame: 1 day

    The difference in the detection rate of colorectal adenomas according to experience by group (Colonoscopists aged 45-55 years/56-65 years/>66 years) between a conventional colonoscopic procedure (CCP) and a conventional colonoscopic procedure (CCP) colonoscopy with AI (ACP).

  7. The difference in the detection rate of colorectal adenomas depending on the time of day .

    Time frame: 1 day

    The difference in the detection rate of colorectal adenomas depending on the time of day (before 11:00/between 11:00 and 15:00/after 15:00) and the number of colonoscopies (Colonoscopy from 1 to 6 per half-day) per group (hyperplastic/conventional adenomas/scalloped adenomas/adenocarcinoma) between a conventional colonoscopic procedure (PCC) and a colonoscopy procedure with AI (ACP).

  8. The difference in the detection rate of colorectal adenomas according to colonic preparation by group (Boston Score 9/6-8/<6) between a conventional colonoscopic procedure (PCC) and a colonoscopy procedure with AI (ACP).

    Time frame: 1 day

    The difference in the adenoma detection rate according to the quality of colonic preparation will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

Study contacts

Contact information is provided by the study sponsor or research team.

Erik Francois, M.D.

CONTACT

[email protected]

32 495 77 00 60

Philippe Langlet, M.D.

CONTACT

[email protected]

32 2 434 8105

Sponsors and collaborators

Lead sponsor

Chirec

Other

Registry information

Official study title

Real-World Experience of Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital: A Single-Center Cohort Phase IV Study

Acronym: Delta-AI

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jan 24, 2025
Registry last updated
Jan 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.